loading

Finanzdaten der Achieve Life Sciences Inc-Aktie (ACHV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
20.68%
5.32
6.707 7.097 7.296 7.609
Costs And Expenses
16.95%
14.69
12.56 12.89 12.19 12.47
Depreciation and Amortization
1.82%
0.054
0.055 0.062 0.058 0.057
Nonoperating Income/Loss
261.94%
0.251
-0.155 0.067 -0.17 -0.046
Income/Loss From Continuing Operations Before Tax
15.52%
-14.69
-12.72 -12.83 -12.36 -12.47
Income/Loss From Continuing Operations After Tax
13.55%
-14.44
-12.72 -12.83 -12.36 -12.51
Net Income/Loss
13.55%
-14.44
-12.72 -12.83 -12.36 -12.51
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
47.09%
51.02
34.69 34.69 0.8191 34.36
Diluted Average Shares
47.09%
51.02
34.69 34.69 0.8191 34.36
Basic Earnings Per Share
24.32%
-0.28
-0.37 -0.37 -0.36 -0.36
Diluted Earnings Per Share
24.32%
-0.28
-0.37 -0.37 -0.36 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$51.76
price up icon 5.78%
$50.15
price down icon 0.81%
$96.68
price up icon 2.09%
$124.45
price down icon 8.95%
$148.62
price down icon 1.89%
ONC ONC
$315.13
price down icon 0.42%
Kapitalisierung:     |  Volumen (24h):